The digital revolution is the fourth industrial revolution. It changes models, processes and whole public sectors. In many reports you will find that, in terms of digitalization, pharma is just next to the public sector, as least digitalized. Pharma just started late. There are many reasons for that – it is one of the most regulated industries with lots of sensitive data involved and many ethical aspects. But the slowed down digitalization has a lot to do with some subjective reasons. Adopting digital technologies requires changing existing models which requires a different mindset – and this is difficult to achieve. Nowadays, in the situation of a global pandemic, we see that digital communication is not only necessary to be successful but it is a must in order to adapt to the New Normality.

Sanofi India Limited has announced the appointment of Deepak...

Pharmaceutical companies must contend with challenges from supply chain lapses (theft, diversion, S.O.P. deviations, product recalls, reverse logistics etc.) counterfeiting and stringent regulations. These challenges get compounded when dealing across the states and country business operations, besides that not only impact tangible profits but also the intangible brand credibility. In this context, there is also a credible increase in public awareness about the genuineness of medicine (in particular medicine that require cold chain) and their predictability of clinical outcomes. Providing visibility and full traceability becomes a paramount importance to both the Industry and the Govt. – A fool proof solution not only brings transparency in the system, but can also be a key differentiator, and undoubtedly can create immense opportunities for a competitive advantage.

In the dynamic world of pharmaceutical marketing, staying ahead of the curve is essential for success. As technology continues to evolve, so do the opportunities for innovative campaigns. One area where pharma marketers can make a significant impact is in raising awareness about non-communicable diseases (NCDs) and promoting real-world studies and clinical trials.

The ongoing debate around branded versus generic medicines in...

In his new position, he will lead teams across...

The PE Playbook: Why Private Equity is the New...

Tez Health and the New Race to Bring Healthcare...

The pharmaceutical industry stands at a critical juncture in...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

In his new position, he will lead teams across...

The PE Playbook: Why Private Equity is the New...

Tez Health and the New Race to Bring Healthcare...

The pharmaceutical industry stands at a critical juncture in...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

In his new position, he will lead teams across...

The PE Playbook: Why Private Equity is the New...

Tez Health and the New Race to Bring Healthcare...

The pharmaceutical industry stands at a critical juncture in...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...

In his new position, he will lead teams across...

The PE Playbook: Why Private Equity is the New...

Tez Health and the New Race to Bring Healthcare...

The pharmaceutical industry stands at a critical juncture in...

In India’s million-strong retail pharmacy universe, oral weight-loss pills...